ISSN : 1301-5680
e-ISSN : 2149-8156
TURKISH JOURNAL OF
THORACIC AND
CARDIOVASCULAR SURGERY
Turkish Journal of Thoracic and Cardiovascular Surgery     
MITRAL VALVE REPLACEMENT WITH ST. JUDE MEDICAL VALVE PROTHESİS: TEN YEARS’ EXPERIENCE IN 179 PATIENTS
H. Tahsin KEÇELİGİL, M. Kemal DEMİRAĞ, Gülsen ERSOY, Muzaffer BAHÇIVAN, Erkan İRİZ, Ferşat KOLBAKIR, Hacı AKAR
Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dalı, SAMSUN
Between January 1989 to June 1999, 179 patients underwent mitral valve replacement with the St. Jude Medical (St. Jude Medical, Inc., St. Paul, Minn., USA) vale: 119 women (%66.48), and 60 men (%33.52), mean age 36 ± 14 years, at the Department of Cardiovascular Surgery in 19 Mayıs University Medical School. In 76 patients, additional surgical interventions were performed. Hospital (early post-operative) mortality was 5.58%. Follow-up extended from 2 to 127 months (mean 58 months). All patients were anticoagulated with warfarin to maintain PT-INR value at 2.0 times control. There were 28 late deaths: 9 (32.1%) were evaluated valve-related: two thromboembolism, two valve thrombosis, two prosthetic valve endocarditis, one major hemorrhage, one paravalvular leak and a one sudden death. The 10 year actuarical patient survival was 78% ± 31.%. Actuarial freedom at 10 years from thromboembolic events was 84.8% ± 2.2%, anticoagulant-related hemorrhage was 89.3% ± 3.1%, valve thrombosis was 96.2% ± 1.3%, prosthetic valve endocarditis was 95.8% ± 1.8%, reoperation was 95.1% ± 1.8%, reoperation was 95.1% ± 2.6%. We think the good clinical results with an acceptable complication rate can be expected when the SJM valve prothesis used for cardiac valve replacement.
Keywords :
Viewed : 9848
Downloaded : 2623